CROSSOVER CAPITAL 2019, LLC
CROSSOVER CAPITAL 2019, LLC is a Pre-seed, Seed and Series C+ fund in the US and Asia writing $1M–$20M checks into Fintech, Healthcare and technology.
- Stages
- Pre-seed, Seed, Series C+
- Sectors
- Fintech, Healthcare, technology
- Check size
- $1M–$20M
- Invests in
- US-wide, Asia
- Founded
- 2023
- Assets under management
- $150M
- Website
- crosscapadvisors.com
Thesis
Crossover Capital 2019, LLC, appears to be a financial advisory firm. Related entities like Crossover Capital Brands LLC and Crossover VC suggest a broader strategy encompassing early-stage venture capital, direct investments, and wealth management. Crossover Capital Brands LLC manages approximately $150 million in assets and invests in companies from pre-seed to pre-IPO stages across technology, healthcare, and financial services, with check sizes ranging from $1 million to $20 million. Crossover Capital Partners, based in Boston, manages less than $150 million across four private funds, focusing on healthcare and emerging Asian markets. Crossover Capital 2019, LLC itself is registered as an Exempt Reporting Adviser and is not currently registered, indicating a specific operational capacity.
Common questions
Does CROSSOVER CAPITAL 2019, LLC invest at the Pre-seed stage?
Yes. CROSSOVER CAPITAL 2019, LLC lists Pre-seed, Seed and Series C+ among the stages it invests in.
What check size does CROSSOVER CAPITAL 2019, LLC write?
CROSSOVER CAPITAL 2019, LLC writes $1M–$20M checks.
Where does CROSSOVER CAPITAL 2019, LLC invest?
CROSSOVER CAPITAL 2019, LLC invests in the US and Asia.